Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

BACKGROUND: The 23-valent polysaccharide pneumococcal vaccine (PPV) is currently recommended in elderly and high-risk adults. However, its efficacy in preventing pneumococcal infections remains controversial. This study assessed the clinical effectiveness of vaccination against invasive pneumococcal...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vila-Corcoles, Angel, Ochoa-Gondar, Olga, Guzmán, Jorge A, Rodriguez-Blanco, Teresa, Salsench, Elisabet, Fuentes, Cruz M
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2848154/
https://ncbi.nlm.nih.gov/pubmed/20298596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-10-73
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky